Oral Iptacopan monotherapy improves outcomes in patients with paroxysmal nocturnal hemoglobinuria: NEJM
France: A recent study has shown improved clinical and hematologic outcomes with iptacopan treatment in anti–C5–treated patients with persistent anemia, in whom iptacopan showed superiority to anti-C5 therapy, and in patients who had not received complement inhibitors. The study was published online in the New England Journal of Medicine on March 14, 2024. A lack […]